WO2003045275A9 - Medical device delivery system - Google Patents

Medical device delivery system

Info

Publication number
WO2003045275A9
WO2003045275A9 PCT/US2002/038289 US0238289W WO03045275A9 WO 2003045275 A9 WO2003045275 A9 WO 2003045275A9 US 0238289 W US0238289 W US 0238289W WO 03045275 A9 WO03045275 A9 WO 03045275A9
Authority
WO
WIPO (PCT)
Prior art keywords
inner member
delivery system
delivery catheter
delivery
distal end
Prior art date
Application number
PCT/US2002/038289
Other languages
French (fr)
Other versions
WO2003045275A3 (en
WO2003045275A2 (en
Inventor
Dusan Pavcnik
Brian C Case
Christopher G Dixon
Jacob A Flagle
Mike Garrison
Andrew K Hoffa
Ray Ii Leonard
Original Assignee
Cook Inc
Univ Oregon Health & Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Inc, Univ Oregon Health & Science filed Critical Cook Inc
Priority to CA2466270A priority Critical patent/CA2466270C/en
Priority to DE60221289T priority patent/DE60221289T2/en
Priority to EP02799890A priority patent/EP1465546B1/en
Priority to AU2002364514A priority patent/AU2002364514B2/en
Publication of WO2003045275A2 publication Critical patent/WO2003045275A2/en
Publication of WO2003045275A3 publication Critical patent/WO2003045275A3/en
Publication of WO2003045275A9 publication Critical patent/WO2003045275A9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/011Instruments for their placement or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/9517Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor

Definitions

  • This invention relates to medical devices and in particular to a delivery system for delivering a medical device to a selected site.
  • Delivery systems have been known for many years, for use with the Seldinger technique and related percutaneous entry techniques for vascular delivery of implants into the vasculature of human or veterinary patients.
  • Such systems typically utilize a wire guide inserted into the vasculature to extend to the site of implantation of a medical device such as a stent, stent graft, filter, occluder, valve or the like.
  • An introducer sheath is placed over a portion of the guide wire, and a catheter inserted over the guide wire within the introducer sheath and beyond its distal tip, with the implant contained within a distal portion of the catheter until the implant is delivered to the site of implantation.
  • the implant is then released from the catheter distal tip and deployed.
  • U.S. Patent No.4,494,531 for delivery of a vena cava filter into the vena cava of the vasculature.
  • the system includes a wire guide with a handle, and a cartridge catheter contains the filter at its distal end in a reduced diameter confinement and having a rear assembly.
  • the cartridge catheter is inserted through the sheath until its distal end reaches the deployment site, whereafter the collapsed filter is deployed by gradually refracting the catheters distal end, while the filter is held axially fixed by a positioning wire guide extending to the proximal end of the filter, to initially expose the distal end of the filter having outwardly curving struts with barbs.
  • the exposed filter then expands so that its distal barbs engage and seat in the vessel wall in cooperation with sharp, forward jabs or manipulation of the catheter, and then the remainder of the filter forms a "bird's nest" and its proximal barbs engage and seat in the vessel wall to anchor the filter in position as the catheter continues to be retracted.
  • the particular filter disclosed in the patent is sold by Cook Incorporated, Bloomington, Indiana as the Gianturco-Roehm BIRD'S NEST Vena Cava Filter.
  • the delivery system includes a delivery catheter having a device- containing region such as, for example, a vascular valve-containing region adjacent to its distal tip, and an inner member within the delivery catheter and movable relatively axially with respect thereto when inserted over a wire guide that is positioned in the vasculature of a patient.
  • the inner member has a reduced diameter portion extending through the device or valve-c ⁇ ritaihing region to a distal tip portion distally of the device or valve-containing region, with the distal tip portion having a maximum diameter approximately the catheter diameter at the distal end thereof.
  • the delivery system of the present invention is particularly useful with valves providing clearance for the inner member to extend through the valve opening when the valve is in a compressed state within the device or valve- containing region of the delivery catheter.
  • the distal end of the inner member extends sufficiently forward of the catheter distal end and the valve to engage the vessel distally of the deployment site, and in cooperation with the nearer proximal portions of the catheter centered within adjacent portions of the vasculature thus tending to center the distal end of the delivery catheter advantageously during valve deployment and also tending to temporarily straighten somewhat the local vessel anatomy.
  • the compressed valve is movable with the inner member relatively axially with respect to the delivery catheter distal end upon actuation of the deployment procedure. The distal end of the valve sufficiently engages the inner member when being released from the distal end of the delivery catheter during catheter retraction to generally remain centered in the vessel and generally aligned parallel to the vessel at the deployment site.
  • the distal tip portion of the inner member is tapered on both its distal and proximal ends, and is advantageously atraumatic during insertion into the patient, and nonsnagging and nondisruptive as the inner member is withdrawn proximally through the valve following expansion and deployment thereof.
  • the inner member includes a small diameter radiolucent or transparent region coinciding with the valve in the device or valve- containing region such that radiopaque markers on the device or valve are easily distinguishable under fluoroscopy during positioning and deployment, as the device or valve is movable with the inner member during positioning and during deployment when the delivery catheter is retracted to expose the device or valve.
  • the delivery system of the present invention is especially useful with devices or valves having lyophilized materials that require hydration before deployment.
  • the inner member proximally of the device or valve-containing region is cylindrical in cross-section but containing a flattened side extending from the valve-containing region to the proximal end of the delivery system.
  • a passageway or lumen is formed between the delivery catheter and inner member for advantageously irrigating and/or hydrating the lyophilized material.
  • Hydration fluid such as water or saline solution is injectable into the delivery system through an injection port such as by use of a syringe, and the fluid is transmitted through the delivery catheter within the region between the flattened side of the inner member and the inner surface of the catheter wall, to reach the compressed valve in the device or valve-containing region for hydration of the lyophilized tissue.
  • a syringe Such hydration is to be performed immediately prior to the insertion of the delivery system into the patient for placement of the valve.
  • the proximal portion of the inner member can have a diameter less than the inner diameter of the delivery catheter to form a passageway or lumen significantly greater in cross- sectional area than the lumen formed by the portion of the flat inner member and the delivery catheter. As a result, greater volumes of irrigation fluid can be delivered to the contained medical device.
  • FIG. 1 depicts a top view of an illustrative preferred embodiment of the medical device delivery system of the present invention
  • FIG.2 depicts an exploded and enlarged view of the delivery catheter and the inner member of the delivery system of FIG. 1;
  • FIG. 3 depicts an enlarged and longitudinally sectioned view of the inner member and the delivery catheter of the delivery system of FIG. 2;
  • FIG. 3A depicts an enlarged and longitudinally sectioned view of an alternative embodiment of the distal tip portion of the inner member of the delivery system of FIG. 2;
  • FIG.4 depicts an enlarged partial and longitudinally sectioned view ofthe inner member inserted through the delivery catheter ofthe delivery system of FIG. 3 with a medical device contained therein;
  • FIG. 4A depicts an enlarged partial and longitudinally sectioned view of an alternative embodiment of the delivery catheter of the delivery system of FIG. 3 with an inner member positioned therethrough;
  • FIG. 5 depicts an enlarged and partially sectioned side view of the Y- adaptor or connector of the medical device delivery system of FIG. 1;
  • FIGS. 6 and 7 depict an alternative embodiment of the Y-adaptor or connector of the delivery system of FIG. 5;
  • FIG. 8 depicts an alternative embodiment of the inner member of the delivery system of FIG. 1, which can be used in combination with the Y-adaptor embodiment of FIGS. 6 and 7;
  • FIG. 9 is a cross-sectional view of the cylindrical ring ofthe intermediate portion 19 of FIG. 8 taken along the line 9-9;
  • FIG. 10 depicts another illustrative embodiment of the positioning arrangement of the delivery system of FIG. 8;
  • FIGS. 11 and 12 depict top and side views of still another illustrative embodiment of a positioning member ofthe delivery system of FIG. 1 in which the distal end of the outer tube is shaped to engage the proximal end of a stent valve medical device;
  • FIGS. 13 and 14 depict top and side views of another illustrative embodiment of the distal tip portion ofthe inner member ofthe delivery system of FIG. 1;
  • FIGS. 15 and 16 depict top and side views of still yet another embodiment of the inner member of the delivery system of FIG. 1;
  • FIG. 17 depicts a pictorial view of still yet another embodiment of the inner member of the delivery system of FIG. 1;
  • FIG. 18 depicts a pictorial view of yet still another embodiment of the inner member and, in particular, the distal tip portion of the inner member of the delivery system of FIG. 1; and FIGS. 19 and 20 depict pictorial and side views of a locking mechanism for fixing the relative position of the inner member and delivery catheter of the delivery system of FIG. 1 in which a check flow valve is utilized instead of a side arm.
  • the present invention is especially useful with a valve stent of the type disclosed in U.S. Patent Application Serial No. 09/777,091 filed February 5, 2001.
  • the stent valve disclosed therein comprising a "square" stent (as disclosed in U.S. Patent No. 6,200,336) with extracellular matrix material such as small intestine submucosa (SIS) material secured thereto extending between the struts and having a valve opening or slit through the material.
  • SIS small intestine submucosa
  • Such a valve stent is deliverable to the treatment site in the vasculature and is deployable without any specific control device within the delivery catheter and simply expands and self-seats in position in the vessel as the catheter distal end is retracted.
  • the valve stent is simply held in position in the valve containing region distally of the larger diameter portion of the inner member immediately proximal thereto, thus overcoming any frictional forces by movement of the catheter inner surface as the catheter is
  • FIG. 1 depicts a top view of an illustrative preferred embodiment of medical device delivery system 10 of the present invention.
  • the delivery system includes delivery catheter 11 having inner lumen 12 through which inner member or dilator 16 is inserted therethrough.
  • Well-known Luer-lock connecter hub 52 is affixed to the proximal end of the delivery catheter.
  • Well-known Touhy-Borst Y- adaptor or connector 38 is connected to the connector hub of the delivery catheter through which inner member 16 is also inserted and extended therethrough. Threaded lock 53 at the proximal end of Y-connector 38 is rotated to fixedly position inner member 16 longitudinally with respect to the delivery catheter and the Y- connector.
  • Side arm 40 of the Y-connector extends laterally at an acute angle proximally from main arm 39.
  • a commercially available Check-Flo valve can be connected to connector hub 52 as depicted in FIG. 20. This valve is available from Cook Inc., Bloomington, IN.
  • a fluid irrigation source (not shown) is connected to side arm 40 via well-known inner interconnecting tubing and valve 54.
  • the side arm ofthe Y-adaptor or connector permits the delivery of a fluid to hydrate lyophilized tissue of the medical device contained in device-containing region 15 of the delivery catheter adjacent the distal end thereof.
  • the medical device that is contained in the delivery system of the present invention is typically delivered percutaneously to a vascular deployment site over a well-known wire guide that is inserted into the vascular system and to the deployment site.
  • Inner lumen 24 extends longitudinally through inner member 16 as well as the delivery system, which is introduced over the wire guide through the inner lumen.
  • FIG. 2 depicts an exploded and enlarged view of delivery catheter 11 and ijiner member 16 of delivery system 10 of FIG. 1.
  • Inner member or dilator 16 is insertable through inner lumen 12 of delivery catheter 11 that extends longitudinally between proximal end 13 and distal end 14.
  • the inner member is also insertable through device-containing region 15 adjacent distal end 14.
  • Inner member 16 includes a distal tip portion 17, proximal portion 18 and intermediate portion 19 disposed between the distal tip portion and the proximal portion.
  • a medical device such as the aforementioned stent valve is positioned around the intermediate portion of the inner member.
  • the medical device is a stent valve including lyophilized tissue material that is affixed to a collapsible wire stent frame.
  • the lyophilized tissue material has a slit therein through which the intermediate portion of the inner member is inserted therethrough and engages the tissue material when the stent valve is positioned around the intermediate portion.
  • the stent valve is maintained in a compressed state or condition by delivery catheter 11 when the inner member and compressed valve are inserted therein.
  • the assembled medical device delivery system 10 has inner member 16 extending through inner lumen 12 and beyond the distal end of delivery catheter 11.
  • the compressed medical device is contained in device-containing region 15 of the delivery catheter adjacent distal end 14 of the delivery catheter.
  • the compressed stent valve is deployed at the desired vascular site by maintaining inner member 16 in a stationary position and withdrawing or pulling back the delivery catheter from the intermediate portion of the inner member.
  • Proximal portion 18 of inner member 16 has a cylindrical outer surface 34 with a recessed or flat portion 35 extending longitudinally therealong and communicating with intermediate portion 19. This recessed or flat portion of the inner member in combination with delivery catheter 11 forms a lumen through which to hydrate the stent valve contained in the intermediate portion of the inner member.
  • An advantage of the present invention is that reduced diameter intermediate portion 19 of the inner member is inserted through and engages the medical device for centering the medical device in the vessel in which the device is being deployed.
  • proximal portion 18 of the inner member includes a blunt distal end 20 to engage the proximal end of the medical device positioned in the intermediate portion 19. This blunt distal end is also effective in holding, for example, just a stent that can be contained in device-containing region 15 and intermediate portion 19. This is most effective when the blunt distal end closely approximates the size of inner lumen 12 of delivery catheter 11.
  • Distal tip portion 17 of inner member 16 includes tapered proximal end 31, tapered distal end 32 and an intermediate segment 33 disposed between the tapered distal and proximal ends.
  • the tapered distal end facilitates atraumatic placement ofthe delivery system to the deployment site.
  • Tapered proximal end 31 advantageously provides atraumatic withdrawal of the inner member through the valve slit or opening after the stent valve has been deployed at the desired vessel site.
  • Intermediate segment 33 approximates the size and shape of inner lumen 12 of delivery catheter 11 so as to provide an atraumatic transition between the assembled inner member and delivery catheter.
  • FIG. 3 depicts an enlarged and longitudinally sectioned view of inner member 16 and delivery catheter 11 of delivery system 10 of FIG.2.
  • Inner member 16 of delivery system 10 includes inner tube 25 of a radiolucent material 26 such as, for example, well-known medical grade nylon 12 polyamide material.
  • a radiolucent material 26 such as, for example, well-known medical grade nylon 12 polyamide material.
  • inner tube 25 is approximately 77 cm in length with an outside diameter of approximately 0.059 inches, an inside diameter of approximately 0.040 inches, and a wall thickness of approximately 0.0095 inches.
  • This inner tube extends almost the entire length of the inner member through proximal portions 18, intermediate portion 19 and distal tip portion 17.
  • the translucent material of the inner tube through intermediate portion 19 of the inner member advantageously provides better fluoroscopic visualization ofthe stent valve contained therearound.
  • the radiolucent material provides very little, if any, interference with the heavier density stent, stent valve material or radiopaque markers thereon.
  • Inner member 16 also includes outer tube 27 coaxially positioned around inner tube 25.
  • outer tube 27 designates the proximal and distal ends of proximal portion 18 of the inner member.
  • outer tube 27 is approximately 70 cm in length with an outside diameter of approximately 0.117 inches, an inside diameter of approximately 0.062 inches, and a wall thickness of approximately 0.0275 inches of a radiopaque material 28 such as well- known nylon 12 polyamide material filled with a high density radiopaque filler material such as tungsten, barium, bismuth, and the like.
  • Outer surface 34 of outer tube 27 includes a recessed or flat portion 35 which forms a fluid lumen with the delivery catheter to hydrate a medical device positioned around intermediate portion 19.
  • This recessed or flat portion 35 is skived into the outer surface of the outer tube approximately 0.012 inches. This recessed or flat portion extends from proximal end portion 18 of the inner member and outer tube and communicates with intermediate portion 19.
  • Proximal end 55 ofthe inner and outer tubes are, for example, thermally attached and flared in a well-known manner for connection to well-known Luer-lock connector hub 56 having threaded female and male parts 57 and 58.
  • Blunt distal end 20 of outer tube 27 is advantageously used to engage the proximal end of a medical device contained around intermediate portion 19.
  • Distal tip section 17 of inner member 16 includes tapered proximal end 31 , tapered distal end 32 and intermediate segment 33 disposed therebetween.
  • the distal tip section is preferably 4.5 cm in length with an outside diameter of approximately 0.117 inches, which is approximately the same as the outside diameter of outer tube 27.
  • the distal tip portion 17 can range in length f rom approximately 1.25 cm to 7 cm.
  • tapered proximal end 31 can range in length from approximately 2.5 mm through 10.0 mm with a preferred length of approximately 5.0 mm. If the tapered proximal end is too short, there will be difficulty in retracting the distal tip portion through the valve orifice or slit.
  • Straight intermediate segment 33 can range from approximately 0.0 through 3.0 cm with a preferred length of approximately 2.0 cm. Should the straight intermediate segment be too short, elastic deformatio of the distal tip portion during forward or reverse motion over a wire guide can lead to poor delivery catheter/inner membertransition orthe exposure ofthe valve chamber and valve. Should the straight intermediate segment 33 be too long, this can lead to difficulties with deployment.
  • Tapered distal end 32 can range in length from approximately 1.0 through 3.0 cm with a preferred length of 2.0 cm. Should tapered distal end 32 be too short, there is the possibility of more trauma to the patient and less optimal performance and trackability ofthe delivery system. Atapered distal end that is too long can create production difficulties or lead to difficulties with device deployment.
  • the distal end of the inner tube 25 extends through tapered proximal end 31 and into straight intermediate segment 33. Byway of example, the diameter of the passageway through these segments is approximately 0.059 inches approximating the outside diameter of inner tube 25.
  • a well-known medical grade adhesive is applied to the outside surface of inner tube 25 about the distal end thereof to fixedly attach the distal end portion thereto.
  • Distal tip portion 17 is formed from a well- known radiopaque nylon 12 polyamide material such as described for outer tube 27.
  • Delivery catheter 11 comprises, for example, a 9.0 French cylindrical tube of radiopaque fluorinated ethylene propylene (FEP) approximately 60 cm in length with an outside diameter of approximately 0.141 inches, an inside diameter of approximately 0.121 inches, and a wall thickness of approximately 0.010 inches.
  • Luer-lock connector hub 52 comprises well-known threaded female and male connector parts 59 and 60, which are affixidly attached to flared proximal end 13 of delivery catheter 11.
  • Device-containing region 15 of the delivery catheter is adjacent distal end 14 of the delivery catheter through which inner lumen 12 extends longitudinally therethrough.
  • FIG. 3A depicts an enlarged and longitudinally sectioned view of an alternative embodiment of distal tip section 17 of inner member 16 of delivery .system 10 of FIG. 3. Similar to FIG. 3, distal tip section 17 of this alternative embodiment includes a translucent inner tube 25 extending into the passageway of the distal tip section. However, distal tip section 17 of this alternative embodiment includes a radiopaque marker band 36 positioned at the proximal end of intermediate segment 33. The distal end of the marker band is counterbored to engage a recessed flange at the proximal end of intermediate segment 33.
  • the marker band is disposed next to the intermediate segment over inner tube 25 and held in position with, for example, a medical-grade adhesive or glue such as a commercially available ultraviolet curable glue like Loctite 3311 glue.
  • a medical-grade adhesive or glue such as a commercially available ultraviolet curable glue like Loctite 3311 glue.
  • This glue can be shaped to form tapered proximal end 31.
  • tapered proximal end 31 can be made part of and/orformed with radiopaque marker band 36.
  • the radiopaque marker band is radiographically visualized so that delivery catheter 11 and distal tip portion 17 of inner member 16 can be visualized during the separation or joining thereof during the delivery process.
  • FIG. 4 depicts an enlarged partial and longitudinally sectioned view of inner member 16 inserted through delivery catheter 11 of delivery system 10 of FIG. 3 with medical device 30 contained therein.
  • the medical device such as the previously described stent valve is positioned around and engaging intermediate portion 19 of the inner member.
  • the medical device is maintained in a compressed condition around the intermediate portion ofthe inner member by delivery catheter 11, and in particular, device-containing region 15 adjacent distal end 14 of the delivery catheter.
  • Distal end 14 of the delivery catheter is positioned around intermediate segment 33 of distal tip portion 17 of the inner member.
  • the distal end of the delivery, catheter is beveled to facilitate a. smooth transition between intermediate segment 33 of the distal tip portion of the inner member.
  • Tapered proximal end 31 of the distal tip portion of the inner member extends to intermediate portion 19 and provides for a smooth atraumatic withdrawal of the inner member through the slit or orifice of the stent valve, medical device when deployed in a vessel.
  • Proximal portion 18 of the inner member includes distal end 20 that is sized approximating the inner lumen of the delivery catheter at least through device-containing region 15.
  • the distal end of the proximal-portion engages the proximal end of medical device 30 and maintains the medical device in a fixed longitudinal position during withdrawal ofthe delivery cathet ⁇ r during deployment of the medical device.
  • the outer surface of the proximal portion and outer tube 27 includes recessed portion 35 that cooperates with the delivery catheter to form irrigation lumen 21 for hydrating lyophilized tissue material 42 of stent valve medical device 30. This irrigation lumen extends from the proximal end region of the inner member to intermediate portion 19.
  • medical device 30 includes wire frame stent 44 with lyophilized tissue material 42 attached thereto.
  • Radiopaque markers 43 are positioned on' the wire frame segments of the stent for flu ⁇ rbsc ⁇ pic visualization of the stent valve ' during placement of the device in the vasculature of a patient.
  • Intermediate portion 19 of inner member includes radiolucent material 26 to further improve the fluburoscopic visualization of the stent valve ' medical device.
  • Inner lumen 24 extending longitudinally through the delivery device and, in particular, inner member 16 is used for guiding the delivery system over a well-known guide wire to the deployment site in the vascular system of the patient.
  • Guide wire 50 extends through inner lumen 24.
  • FIG. 4A depicts an enlarged partial and longitudinally sectioned view of an alternative embodiment of delivery catheter 11 of delivery system 10 of FIG. 4 with inner member 16 insertedtherein.
  • Delivery catheter 11 comprises a cylindrical tube 37 of, for example, a radiopaque fluorinated ethylene propylene material with a device-containing region 15 of a cylindrical tube 83 of a clear or transparent non- radiopaque fluorinated ethylene propylene material thermally bonded to radiopaque tube 37 at the distal end thereof.
  • the two tubes are thermally bonded at tapered bonding area 23. The strength of the thermal bond is improved by tapering the one end of one tube and correspondingly beveling the matching end ofthe othertube.
  • the transparent tube allows for visual inspection ofthe medical device such as a venous valve contained within region 15 of the delivery catheter and around the recessed portion of inner member 16.
  • the transparent tube 21 allows a check for migration, for example, of ! a' ⁇ nedical device containing lyophilized small intestine submucosa which is used, for example, in a venous valve. Not only can hydration be verified through the trahspare ⁇ ttube, but a visual check can also be made to verify the absence of air emboli in the catheter.
  • coaxial outer tube 27 has been reduced in its outer diameter by one French size so as to create an approximately 0.017 to 0.018 inch difference from that of the previously described embodiment.
  • recessed or flat portion 35 is no longer needed since the outer tube is smaller in its outer diameter thus allowing for an irrigation or hydration lumen 41 to be created between inner member 16 and delivery catheter 11.
  • FIG.5 depicts an enlarged and partially sectioned side view of Y-adaptor or connector 38 of medical device delivery system 10.
  • ' Distal connector 61 of the Y-adaptor is connected to Luer-lock connector hub 52 of the delivery catheter.
  • Threaded lock 53 is positioned at the proximal end of the Y-adaptor for fixedly positioning inner member 16 longitudinally therein, the inner member extends through main arm 39 of the Y-adaptor and through the delivery catheter.
  • the threaded parts of threaded lock 53 compress well-known flexible polymeric material seal 62 to engage and fixedly position the inner member.
  • flexible polymeric material seal 62 also forms a hemostatic seal at the proximal end of main arm lumen 64 for preventing blood flow from the patient.
  • Y-adaptor 38 also includes side arm 40 connected to interconnecting tubing and valve 54.
  • the side arm includes irrigation lumen 63 extending longitudinally therethrough and communicating with main arm lumen 64.
  • Inner member 16 is longitudinally positioned in main arm lumen 64 such that proximal end region 22 with recessed or flat portion 35 is in communication with side arm lumen 63.
  • the recessed portion of outer surface 34 of the inner member in combination with the inner lumen of the delivery catheter and Y-adaptor forms irrigation lumen 21 for hydrating the lyophilized tissue material ofthe stent valve medical device contained around the intermediate portion of the inner member.
  • FIGS. 6 and 7 depict an alternative illustrative embodiment of Y-adaptor or connector 38 of delivery system 10 of FIG. 5.
  • inner member 16 extends longitudinally through main arm lumen 64 as previously described with recessed or flat portion 35 in fluid communication with side arm lumen 63.
  • Flexible polymeric material seal 62 now takes on the form of an O ring to facilitate a hemostatic seal between the inner member and the Y-adaptbr.
  • proximal end 65 of the Y-adaptor are apertures 66 and 67 extending transversely therethrough.
  • a pair of transversely oriented, diametrically facing slots 68 are formed in inner member 16, which align with apertures 66 and 67 ofthe Y-adaptor.
  • Two prong key 69 is inserted through the apertures and slots for fixedly positioning the inner member relative to the Y-adaptor.
  • this is also utilized in combination with other structures which ' will be described hereinafter to rotatio ⁇ ally fix the position of the stent valve medical device contained at the distal end of the delivery catheter.
  • FIG.8 depicts an alternative illustrative embodiment of inner member 16 of delivery system 10 of FIG. 1, which can be used in combination with the Y- adaptor embodiment of FIGS.6 and 7.
  • a cylindrical ring 70 of a flexible atraumatic material such as silicone and the like. This cylindrical ring of flexible material is positioned near the center of the intermediate portion ofthe inner member so as to engage wire frame segments or members of the stent valve medical device contained in the delivery system.
  • FIG.9 depicts a cross-sectional view of cylindrical ring 70 of intermediate portion 19 of FIG. 8 taken along the line 9-9 containing wire frame members 71 in delivery catheter 11.
  • cylindrical ring 70 is circumferentially positioned around inner tube 25 with delivery catheter 11 surrounding cylindrical ring 70 and wire frame members 71 of the contained medical device.
  • the stent valve medical device of the present device is fixedly positioned circumferentially and longitudinally in the delivery system.
  • the key at the proximal end ofthe Y-adaptor of FIG. 6 and 7 can be used to visually indicate the rotational orientation ofthe stent valve medical device contained in the delivery catheter at the distal end of the delivery system.
  • FIG. 10 depicts another illustrative embodiment of the positioning arrangement of delivery system 10 of FIG. 8.
  • the positioning member comprises a sleeve 72 having a cross-sectional shape with an elliptical circumference 73.
  • the wire frame members or segments ofthe stent valve are positioned on either side ofthe major axis of the elliptically shaped sleeve.
  • the orientation ofthe sleeve is aligned with that of the lock on the proximal end of the inner member to provide visual orientation of the stent valve contained at the distal end of the delivery system.
  • FIGS. 11 and 12 depict top and side views of still another illustrative embodiment of a positioning arrangement ofthe delivery system of FIG. 1 in which distal end 29 of outer tube 27 is shaped to engage one end of the stent valve medical device.
  • the top and bottom of outer tube 27 have been skived or recessed so as to allow the wire frame segments to reside on either side of the tube.
  • Recessed portions 74 and 75 engage the wire frame members of the device when contained in the delivery catheter.
  • FIG. 12 depicts a top view of the outer tube with the sides ofthe tube beveled or tapered to form a duckbill configuration.
  • FIGS. 13 and 14 depict top and side views of another illustrative embodiment of distal tip portion 17 of the inner member of the delivery system of FIG. 1.
  • the proximal end 31 of the distal tip portion has been recessed on both sides as indicated by curvilinear surfaces 76 and 77.
  • these curvilinear surfaces allow the other end as indicated by phantom lines 78 of the stent valve medical device to reside on the oppositely facing surfaces.
  • the proximal end of curvilinear surface 76 has been rounded to minimize trauma or damage to surrounding tissue or the lyophilized tissue material of the stent valve.
  • FIGS. 15 and 16 depicttop and side views of still yet another embodiment of inner member 16 of the delivery system of FIG. 1.
  • proximal end 31 of distal tip portion 17 includes oppositely facing curvilinear surfaces 76 and 77.
  • Distal end 20 of outer tube 27 has oppositely facing recessed surfaces 74 and 75.
  • Distal tip portion 17 and ⁇ utert ⁇ be ! 27 afe circumferentially positioned on inner tube 25 such that curvilinear 76 afid 77 are 90 degrees out of phase with respect to oppositely facing recessed 'surfaces ' 74 arid 75.
  • the 90 degrees out of phase ends as indicated by phantom lines 78 and 79 of the wire frame stent are engaged by and contained by the recessed surfaces.
  • FIG. 17 depicts a pictorial view of still yet another embodiment of inner member 16 of the delivery system of FIG. 1.
  • radiopaque markers can be used with any of the embodiments previously discussed to further visualize the orientation of the stent valve medical device or the distal end of the proximal end portion of themiter ' member.
  • FIG. 18 depicts a pictorial view of yet still another embodiment of inner member 16 and, in particular, distal tip portion 17 of the delivery system of FIG. 1.
  • tapered proximal end 31 of distal tip portion 17 includes longitudinally offset recesses 45 and 46.
  • Offset 45 has a diametrically opposed recess on the circumference of tapered proximal end 31, whereas offset recess 46 likewise has a corresponding diametrically opposed recess on the circumference ofthe tapered proximal end 31.
  • These two pairs ofdiarr ⁇ etrically opposed recesses are offset from one another to accept a pair of long struts of, for example, a venous valve in recess pair 46 and to accept a pair of shorter struts in longitudinal recess pair 45.
  • These offset recesses capture the ends ofthe two different iength struts so as to maintain circumferential orientation of the medical device during placement. Furthermore, the medical device can be rotated with these longitudinally offset recesses for precise placement in the vasculature of a patient.
  • FIGS. 19 and 20 depict pictorial and side views of locking mechanism 47 of the delivery system of the present invention for fixedly positioning the relative position of delivery catheter 11 with respect to dilator or inner member 16.
  • a well-known and commercially available Check-Flo valve 48 with side arm 82 is connected to or made part of the proximal end of delivery catheter 11.
  • This valve has an annular recess therearound as does the: distal end of inner member 16, which includes a well-known Luer-lock connector hub at its distal end.
  • locking mechanism 47 includes a pair of C-shaped cl ⁇ ps'; ! which are interconnected by tie bar 47.
  • the C-shaped clips of the locking mechanism are each clipped into a respective recess at the distal end of the delivery catheter and inner member so as to fix the relative position of each to one another.
  • This locking mechanism can be readily removed by the attending physician when it is desired to withdraw the delivery catheter from the contained medical device.
  • the locking mechanism advantageously prevents premature deployment of the medical device during the delivery and implantation procedure.
  • the distal end of the proximal portion of the inner member may be configured to engage the proximal end of the medical device positioned in the intermediate portion of the inner member.
  • the proximal end of the distal tip portion of the inner member can be configured in any number of different ways to receive and engage the distal end of the medical device. These configurations are used to engage and rotate the medical device while still being able to determine the orientation of the medical ' devieVfrom the proximal end of the delivery system typically positioned outside of the patient during a purcutaneous vascular procedure.
  • the present invention is useful for placement of a medical implantable device within a human or veterinary patient, and therefore finds applicability in human and veterinary medicine.

Abstract

A delivery system (10) for implanting a medical device (30) such as a venous valve into the vasculature of a patient. The delivery system includes a delivery catheter (11) having a device-containing portion (15) adjacent to the distal end (14) thereof, and an inner member (16) extending through the catheter and beyond the distal end thereof, to an atraumatic distal tip portion (17) forward of the catheter distal end. The inner member extends through the medical device in the device-containing region, includes a proximal portion (18) with sufficiently large diameter to prevent longitudinal movement of the device as the catheter is retracted during deployment, and centers the device upon release from the distal catheter end during deployment. The inner member is preferably radiolucent underlying the device for contrast with radiopaque markers (43) of the device. The inner member preferably includes a flat portion (35) extending from the device-containing portion to the proximal end (22) to form a passageway or lumen (21) with the delivery catheter to transmit hydrating fluid to a device such as a valve containing lyophilized tissue requiring hydration immediately prior to patient implantation.

Description

MEDICAL DEVICE DELIVERY SYSTEM
Description Technical Field
This invention relates to medical devices and in particular to a delivery system for delivering a medical device to a selected site. Background of the Invention
Delivery systems have been known for many years, for use with the Seldinger technique and related percutaneous entry techniques for vascular delivery of implants into the vasculature of human or veterinary patients. Such systems typically utilize a wire guide inserted into the vasculature to extend to the site of implantation of a medical device such as a stent, stent graft, filter, occluder, valve or the like. An introducer sheath is placed over a portion of the guide wire, and a catheter inserted over the guide wire within the introducer sheath and beyond its distal tip, with the implant contained within a distal portion of the catheter until the implant is delivered to the site of implantation. The implant is then released from the catheter distal tip and deployed. The insertion and progress of the procedure are monitored closely through fluoroscopy/'angiograms or CT scanning or the like, in> which radiopaque markers are commonly used as landmarks on the- wire "guide, catheter and implantable device to assure eventual accurate positioning of the device at the site of implantation and its full deployment. '
One delivery system is known from U.S. Patent No.4,494,531 for delivery of a vena cava filter into the vena cava of the vasculature. The system includes a wire guide with a handle, and a cartridge catheter contains the filter at its distal end in a reduced diameter confinement and having a rear assembly. Once access is gained to the vasculature by an introducer sheath and a dilator, and the dilator is removed from the sheath, the cartridge catheter is inserted through the sheath until its distal end reaches the deployment site, whereafter the collapsed filter is deployed by gradually refracting the catheters distal end, while the filter is held axially fixed by a positioning wire guide extending to the proximal end of the filter, to initially expose the distal end of the filter having outwardly curving struts with barbs. The exposed filter then expands so that its distal barbs engage and seat in the vessel wall in cooperation with sharp, forward jabs or manipulation of the catheter, and then the remainder of the filter forms a "bird's nest" and its proximal barbs engage and seat in the vessel wall to anchor the filter in position as the catheter continues to be retracted. The particular filter disclosed in the patent is sold by Cook Incorporated, Bloomington, Indiana as the Gianturco-Roehm BIRD'S NEST Vena Cava Filter.
Delivery systems for filters are also disclosed in U.S. Patent Nos. 5,329,942 and 5,324,304, wherein the filter is released at the deployment site by retraction of the cathete distal end from therearound as the proximal filter end is held in place axially..
It is desired to "provide a delivery system for medical devices such as vascular valves that provides for assuredly centering the distal ends of valves during deployment from the delivery catheter.
It is also desired to provide such a medical device delivery system that does not interfere with precise visualization of radiopaque markers on the medical device such as a vascular valve being implanted.
It is further desired to provide such a delivery system to have a minimized diameter for use with medical devices such as vascular valves containing lyophilized tissue that enables hydration of the lybphilized tissue at the time of delivery into the patient. Summary of the Invention -
The foregoing problems are solved and a technological advance is achieved by an:'illustrative embodiment of a medical device delivery system of the present invention. The delivery system includes a delivery catheter having a device- containing region such as, for example, a vascular valve-containing region adjacent to its distal tip, and an inner member within the delivery catheter and movable relatively axially with respect thereto when inserted over a wire guide that is positioned in the vasculature of a patient. The inner member has a reduced diameter portion extending through the device or valve-cσritaihing region to a distal tip portion distally of the device or valve-containing region, with the distal tip portion having a maximum diameter approximately the catheter diameter at the distal end thereof. The delivery system of the present invention is particularly useful with valves providing clearance for the inner member to extend through the valve opening when the valve is in a compressed state within the device or valve- containing region of the delivery catheter.
The distal end of the inner member extends sufficiently forward of the catheter distal end and the valve to engage the vessel distally of the deployment site, and in cooperation with the nearer proximal portions of the catheter centered within adjacent portions of the vasculature thus tending to center the distal end of the delivery catheter advantageously during valve deployment and also tending to temporarily straighten somewhat the local vessel anatomy. The compressed valve is movable with the inner member relatively axially with respect to the delivery catheter distal end upon actuation of the deployment procedure. The distal end of the valve sufficiently engages the inner member when being released from the distal end of the delivery catheter during catheter retraction to generally remain centered in the vessel and generally aligned parallel to the vessel at the deployment site. Preferably, the distal tip portion of the inner member is tapered on both its distal and proximal ends, and is advantageously atraumatic during insertion into the patient, and nonsnagging and nondisruptive as the inner member is withdrawn proximally through the valve following expansion and deployment thereof.
In another aspect, the inner member includes a small diameter radiolucent or transparent region coinciding with the valve in the device or valve- containing region such that radiopaque markers on the device or valve are easily distinguishable under fluoroscopy during positioning and deployment, as the device or valve is movable with the inner member during positioning and during deployment when the delivery catheter is retracted to expose the device or valve.
In a third aspect, the delivery system of the present invention is especially useful with devices or valves having lyophilized materials that require hydration before deployment. The inner member proximally of the device or valve-containing region is cylindrical in cross-section but containing a flattened side extending from the valve-containing region to the proximal end of the delivery system. Thus, a passageway or lumen is formed between the delivery catheter and inner member for advantageously irrigating and/or hydrating the lyophilized material. Hydration fluid such as water or saline solution is injectable into the delivery system through an injection port such as by use of a syringe, and the fluid is transmitted through the delivery catheter within the region between the flattened side of the inner member and the inner surface of the catheter wall, to reach the compressed valve in the device or valve-containing region for hydration of the lyophilized tissue. Such hydration is to be performed immediately prior to the insertion of the delivery system into the patient for placement of the valve. Alternatively, the proximal portion of the inner member can have a diameter less than the inner diameter of the delivery catheter to form a passageway or lumen significantly greater in cross- sectional area than the lumen formed by the portion of the flat inner member and the delivery catheter. As a result, greater volumes of irrigation fluid can be delivered to the contained medical device. Brief Description of the Drawing
Embodiments of the delivery system of the present invention will now be described by way of example with reference to the accompanying drawings, in which:
FIG. 1 depicts a top view of an illustrative preferred embodiment of the medical device delivery system of the present invention;
FIG.2 depicts an exploded and enlarged view of the delivery catheter and the inner member of the delivery system of FIG. 1;
FIG. 3 depicts an enlarged and longitudinally sectioned view of the inner member and the delivery catheter of the delivery system of FIG. 2;
FIG. 3A depicts an enlarged and longitudinally sectioned view of an alternative embodiment of the distal tip portion of the inner member of the delivery system of FIG. 2; FIG.4 depicts an enlarged partial and longitudinally sectioned view ofthe inner member inserted through the delivery catheter ofthe delivery system of FIG. 3 with a medical device contained therein;
FIG. 4A depicts an enlarged partial and longitudinally sectioned view of an alternative embodiment of the delivery catheter of the delivery system of FIG. 3 with an inner member positioned therethrough;
FIG. 5 depicts an enlarged and partially sectioned side view of the Y- adaptor or connector of the medical device delivery system of FIG. 1;
FIGS. 6 and 7 depict an alternative embodiment of the Y-adaptor or connector of the delivery system of FIG. 5;
FIG. 8 depicts an alternative embodiment of the inner member of the delivery system of FIG. 1, which can be used in combination with the Y-adaptor embodiment of FIGS. 6 and 7;
FIG. 9 is a cross-sectional view of the cylindrical ring ofthe intermediate portion 19 of FIG. 8 taken along the line 9-9;
FIG. 10 depicts another illustrative embodiment of the positioning arrangement of the delivery system of FIG. 8;
FIGS. 11 and 12 depict top and side views of still another illustrative embodiment of a positioning member ofthe delivery system of FIG. 1 in which the distal end of the outer tube is shaped to engage the proximal end of a stent valve medical device;
FIGS. 13 and 14 depict top and side views of another illustrative embodiment of the distal tip portion ofthe inner member ofthe delivery system of FIG. 1;
FIGS. 15 and 16 depict top and side views of still yet another embodiment of the inner member of the delivery system of FIG. 1;
FIG. 17 depicts a pictorial view of still yet another embodiment of the inner member of the delivery system of FIG. 1;
FIG. 18 depicts a pictorial view of yet still another embodiment of the inner member and, in particular, the distal tip portion of the inner member of the delivery system of FIG. 1; and FIGS. 19 and 20 depict pictorial and side views of a locking mechanism for fixing the relative position of the inner member and delivery catheter of the delivery system of FIG. 1 in which a check flow valve is utilized instead of a side arm. Detailed Description
The present invention is especially useful with a valve stent of the type disclosed in U.S. Patent Application Serial No. 09/777,091 filed February 5, 2001. The stent valve disclosed therein comprising a "square" stent (as disclosed in U.S. Patent No. 6,200,336) with extracellular matrix material such as small intestine submucosa (SIS) material secured thereto extending between the struts and having a valve opening or slit through the material. Such a valve stent is deliverable to the treatment site in the vasculature and is deployable without any specific control device within the delivery catheter and simply expands and self-seats in position in the vessel as the catheter distal end is retracted. The valve stent is simply held in position in the valve containing region distally of the larger diameter portion of the inner member immediately proximal thereto, thus overcoming any frictional forces by movement of the catheter inner surface as the catheter is retracted.
FIG. 1 depicts a top view of an illustrative preferred embodiment of medical device delivery system 10 of the present invention. The delivery system includes delivery catheter 11 having inner lumen 12 through which inner member or dilator 16 is inserted therethrough. Well-known Luer-lock connecter hub 52 is affixed to the proximal end of the delivery catheter. Well-known Touhy-Borst Y- adaptor or connector 38 is connected to the connector hub of the delivery catheter through which inner member 16 is also inserted and extended therethrough. Threaded lock 53 at the proximal end of Y-connector 38 is rotated to fixedly position inner member 16 longitudinally with respect to the delivery catheter and the Y- connector. Side arm 40 of the Y-connector extends laterally at an acute angle proximally from main arm 39. Alternatively, a commercially available Check-Flo valve can be connected to connector hub 52 as depicted in FIG. 20. This valve is available from Cook Inc., Bloomington, IN. A fluid irrigation source (not shown) is connected to side arm 40 via well-known inner interconnecting tubing and valve 54. The side arm ofthe Y-adaptor or connector permits the delivery of a fluid to hydrate lyophilized tissue of the medical device contained in device-containing region 15 of the delivery catheter adjacent the distal end thereof. The medical device that is contained in the delivery system of the present invention is typically delivered percutaneously to a vascular deployment site over a well-known wire guide that is inserted into the vascular system and to the deployment site. Inner lumen 24 extends longitudinally through inner member 16 as well as the delivery system, which is introduced over the wire guide through the inner lumen.
FIG. 2 depicts an exploded and enlarged view of delivery catheter 11 and ijiner member 16 of delivery system 10 of FIG. 1. Inner member or dilator 16 is insertable through inner lumen 12 of delivery catheter 11 that extends longitudinally between proximal end 13 and distal end 14. In particular, the inner member is also insertable through device-containing region 15 adjacent distal end 14. Inner member 16 includes a distal tip portion 17, proximal portion 18 and intermediate portion 19 disposed between the distal tip portion and the proximal portion. A medical device such as the aforementioned stent valve is positioned around the intermediate portion of the inner member. In this particular embodiment, the medical device is a stent valve including lyophilized tissue material that is affixed to a collapsible wire stent frame. The lyophilized tissue material has a slit therein through which the intermediate portion of the inner member is inserted therethrough and engages the tissue material when the stent valve is positioned around the intermediate portion. The stent valve is maintained in a compressed state or condition by delivery catheter 11 when the inner member and compressed valve are inserted therein. The assembled medical device delivery system 10 has inner member 16 extending through inner lumen 12 and beyond the distal end of delivery catheter 11. The compressed medical device is contained in device-containing region 15 of the delivery catheter adjacent distal end 14 of the delivery catheter. The compressed stent valve is deployed at the desired vascular site by maintaining inner member 16 in a stationary position and withdrawing or pulling back the delivery catheter from the intermediate portion of the inner member.
Proximal portion 18 of inner member 16 has a cylindrical outer surface 34 with a recessed or flat portion 35 extending longitudinally therealong and communicating with intermediate portion 19. This recessed or flat portion of the inner member in combination with delivery catheter 11 forms a lumen through which to hydrate the stent valve contained in the intermediate portion of the inner member. An advantage of the present invention is that reduced diameter intermediate portion 19 of the inner member is inserted through and engages the medical device for centering the medical device in the vessel in which the device is being deployed. To maintain the longitudinal position of the medical device in the vessel during deployment, proximal portion 18 of the inner member includes a blunt distal end 20 to engage the proximal end of the medical device positioned in the intermediate portion 19. This blunt distal end is also effective in holding, for example, just a stent that can be contained in device-containing region 15 and intermediate portion 19. This is most effective when the blunt distal end closely approximates the size of inner lumen 12 of delivery catheter 11.
Distal tip portion 17 of inner member 16 includes tapered proximal end 31, tapered distal end 32 and an intermediate segment 33 disposed between the tapered distal and proximal ends. The tapered distal end facilitates atraumatic placement ofthe delivery system to the deployment site. Tapered proximal end 31 advantageously provides atraumatic withdrawal of the inner member through the valve slit or opening after the stent valve has been deployed at the desired vessel site. Intermediate segment 33 approximates the size and shape of inner lumen 12 of delivery catheter 11 so as to provide an atraumatic transition between the assembled inner member and delivery catheter.
FIG. 3 depicts an enlarged and longitudinally sectioned view of inner member 16 and delivery catheter 11 of delivery system 10 of FIG.2. Inner member 16 of delivery system 10 includes inner tube 25 of a radiolucent material 26 such as, for example, well-known medical grade nylon 12 polyamide material. By way of example, inner tube 25 is approximately 77 cm in length with an outside diameter of approximately 0.059 inches, an inside diameter of approximately 0.040 inches, and a wall thickness of approximately 0.0095 inches. This inner tube extends almost the entire length of the inner member through proximal portions 18, intermediate portion 19 and distal tip portion 17. The translucent material of the inner tube through intermediate portion 19 of the inner member advantageously provides better fluoroscopic visualization ofthe stent valve contained therearound. The radiolucent material provides very little, if any, interference with the heavier density stent, stent valve material or radiopaque markers thereon.
Inner member 16 also includes outer tube 27 coaxially positioned around inner tube 25. For all practical purposes, outer tube 27 designates the proximal and distal ends of proximal portion 18 of the inner member. By way of example, outer tube 27 is approximately 70 cm in length with an outside diameter of approximately 0.117 inches, an inside diameter of approximately 0.062 inches, and a wall thickness of approximately 0.0275 inches of a radiopaque material 28 such as well- known nylon 12 polyamide material filled with a high density radiopaque filler material such as tungsten, barium, bismuth, and the like. Outer surface 34 of outer tube 27 includes a recessed or flat portion 35 which forms a fluid lumen with the delivery catheter to hydrate a medical device positioned around intermediate portion 19. This recessed or flat portion 35 is skived into the outer surface of the outer tube approximately 0.012 inches. This recessed or flat portion extends from proximal end portion 18 of the inner member and outer tube and communicates with intermediate portion 19. Proximal end 55 ofthe inner and outer tubes are, for example, thermally attached and flared in a well-known manner for connection to well-known Luer-lock connector hub 56 having threaded female and male parts 57 and 58. Blunt distal end 20 of outer tube 27 is advantageously used to engage the proximal end of a medical device contained around intermediate portion 19.
Distal tip section 17 of inner member 16 includes tapered proximal end 31 , tapered distal end 32 and intermediate segment 33 disposed therebetween. By way of example, the distal tip section is preferably 4.5 cm in length with an outside diameter of approximately 0.117 inches, which is approximately the same as the outside diameter of outer tube 27. The distal tip portion 17 can range in length f rom approximately 1.25 cm to 7 cm. By way of further example, tapered proximal end 31 can range in length from approximately 2.5 mm through 10.0 mm with a preferred length of approximately 5.0 mm. If the tapered proximal end is too short, there will be difficulty in retracting the distal tip portion through the valve orifice or slit. In addition, there can be possible induced migration of the valve along with possible damage to the valve itself. Should the tapered proximal end be too long, there is the possibility of wedging the valve between the distal tip portion and the delivery catheter. A taper that is too long may also lead to difficulties with deployment of the stent valve.
Straight intermediate segment 33 can range from approximately 0.0 through 3.0 cm with a preferred length of approximately 2.0 cm. Should the straight intermediate segment be too short, elastic deformatio of the distal tip portion during forward or reverse motion over a wire guide can lead to poor delivery catheter/inner membertransition orthe exposure ofthe valve chamber and valve. Should the straight intermediate segment 33 be too long, this can lead to difficulties with deployment.
Tapered distal end 32 can range in length from approximately 1.0 through 3.0 cm with a preferred length of 2.0 cm. Should tapered distal end 32 be too short, there is the possibility of more trauma to the patient and less optimal performance and trackability ofthe delivery system. Atapered distal end that is too long can create production difficulties or lead to difficulties with device deployment. As depicted, the distal end of the inner tube 25 extends through tapered proximal end 31 and into straight intermediate segment 33. Byway of example, the diameter of the passageway through these segments is approximately 0.059 inches approximating the outside diameter of inner tube 25. A well-known medical grade adhesive is applied to the outside surface of inner tube 25 about the distal end thereof to fixedly attach the distal end portion thereto. The remaining portion ofthe lumen extending through the distal tip portion is approximately 0.038 inches to accommodate a 0.38 inch wire guide. Distal tip portion 17 is formed from a well- known radiopaque nylon 12 polyamide material such as described for outer tube 27. Delivery catheter 11 comprises, for example, a 9.0 French cylindrical tube of radiopaque fluorinated ethylene propylene (FEP) approximately 60 cm in length with an outside diameter of approximately 0.141 inches, an inside diameter of approximately 0.121 inches, and a wall thickness of approximately 0.010 inches. Luer-lock connector hub 52 comprises well-known threaded female and male connector parts 59 and 60, which are affixidly attached to flared proximal end 13 of delivery catheter 11. Device-containing region 15 of the delivery catheter is adjacent distal end 14 of the delivery catheter through which inner lumen 12 extends longitudinally therethrough.
FIG. 3A depicts an enlarged and longitudinally sectioned view of an alternative embodiment of distal tip section 17 of inner member 16 of delivery .system 10 of FIG. 3. Similar to FIG. 3, distal tip section 17 of this alternative embodiment includes a translucent inner tube 25 extending into the passageway of the distal tip section. However, distal tip section 17 of this alternative embodiment includes a radiopaque marker band 36 positioned at the proximal end of intermediate segment 33. The distal end of the marker band is counterbored to engage a recessed flange at the proximal end of intermediate segment 33. The marker band is disposed next to the intermediate segment over inner tube 25 and held in position with, for example, a medical-grade adhesive or glue such as a commercially available ultraviolet curable glue like Loctite 3311 glue. This glue can be shaped to form tapered proximal end 31. Alternatively, tapered proximal end 31 can be made part of and/orformed with radiopaque marker band 36. As a result, the radiopaque marker band is radiographically visualized so that delivery catheter 11 and distal tip portion 17 of inner member 16 can be visualized during the separation or joining thereof during the delivery process.
FIG. 4 depicts an enlarged partial and longitudinally sectioned view of inner member 16 inserted through delivery catheter 11 of delivery system 10 of FIG. 3 with medical device 30 contained therein. The medical device such as the previously described stent valve is positioned around and engaging intermediate portion 19 of the inner member. The medical device is maintained in a compressed condition around the intermediate portion ofthe inner member by delivery catheter 11, and in particular, device-containing region 15 adjacent distal end 14 of the delivery catheter. Distal end 14 of the delivery catheter is positioned around intermediate segment 33 of distal tip portion 17 of the inner member. The distal end of the delivery, catheter is beveled to facilitate a. smooth transition between intermediate segment 33 of the distal tip portion of the inner member. Tapered proximal end 31 of the distal tip portion of the inner member extends to intermediate portion 19 and provides for a smooth atraumatic withdrawal of the inner member through the slit or orifice of the stent valve, medical device when deployed in a vessel.
Proximal portion 18 of the inner member includes distal end 20 that is sized approximating the inner lumen of the delivery catheter at least through device-containing region 15. The distal end of the proximal-portion engages the proximal end of medical device 30 and maintains the medical device in a fixed longitudinal position during withdrawal ofthe delivery cathetέr during deployment of the medical device. As previously suggested, the outer surface of the proximal portion and outer tube 27 includes recessed portion 35 that cooperates with the delivery catheter to form irrigation lumen 21 for hydrating lyophilized tissue material 42 of stent valve medical device 30. This irrigation lumen extends from the proximal end region of the inner member to intermediate portion 19. As also previously suggested, medical device 30 includes wire frame stent 44 with lyophilized tissue material 42 attached thereto. Radiopaque markers 43 are positioned on' the wire frame segments of the stent for fluόrbscόpic visualization of the stent valve'during placement of the device in the vasculature of a patient. Intermediate portion 19 of inner member includes radiolucent material 26 to further improve the fluburoscopic visualization of the stent valve 'medical device. Inner lumen 24 extending longitudinally through the delivery device and, in particular, inner member 16 is used for guiding the delivery system over a well-known guide wire to the deployment site in the vascular system of the patient. Guide wire 50 extends through inner lumen 24.
FIG. 4A depicts an enlarged partial and longitudinally sectioned view of an alternative embodiment of delivery catheter 11 of delivery system 10 of FIG. 4 with inner member 16 insertedtherein. Delivery catheter 11 comprises a cylindrical tube 37 of, for example, a radiopaque fluorinated ethylene propylene material with a device-containing region 15 of a cylindrical tube 83 of a clear or transparent non- radiopaque fluorinated ethylene propylene material thermally bonded to radiopaque tube 37 at the distal end thereof. The two tubes are thermally bonded at tapered bonding area 23. The strength of the thermal bond is improved by tapering the one end of one tube and correspondingly beveling the matching end ofthe othertube. The transparent tube allows for visual inspection ofthe medical device such as a venous valve contained within region 15 of the delivery catheter and around the recessed portion of inner member 16. In addition, the transparent tube 21 allows a check for migration, for example, of !a'τnedical device containing lyophilized small intestine submucosa which is used, for example, in a venous valve. Not only can hydration be verified through the trahspareήttube, but a visual check can also be made to verify the absence of air emboli in the catheter. In this alternative embodiment depicted in FIG.4A, coaxial outer tube 27 has been reduced in its outer diameter by one French size so as to create an approximately 0.017 to 0.018 inch difference from that of the previously described embodiment. As a result, recessed or flat portion 35 is no longer needed since the outer tube is smaller in its outer diameter thus allowing for an irrigation or hydration lumen 41 to be created between inner member 16 and delivery catheter 11.
FIG.5 depicts an enlarged and partially sectioned side view of Y-adaptor or connector 38 of medical device delivery system 10.' Distal connector 61 of the Y-adaptor is connected to Luer-lock connector hub 52 of the delivery catheter. Threaded lock 53 is positioned at the proximal end of the Y-adaptor for fixedly positioning inner member 16 longitudinally therein, the inner member extends through main arm 39 of the Y-adaptor and through the delivery catheter. The threaded parts of threaded lock 53 compress well-known flexible polymeric material seal 62 to engage and fixedly position the inner member. In addition, flexible polymeric material seal 62 also forms a hemostatic seal at the proximal end of main arm lumen 64 for preventing blood flow from the patient. Y-adaptor 38 also includes side arm 40 connected to interconnecting tubing and valve 54. The side arm includes irrigation lumen 63 extending longitudinally therethrough and communicating with main arm lumen 64. Inner member 16 is longitudinally positioned in main arm lumen 64 such that proximal end region 22 with recessed or flat portion 35 is in communication with side arm lumen 63. The recessed portion of outer surface 34 of the inner member in combination with the inner lumen of the delivery catheter and Y-adaptor forms irrigation lumen 21 for hydrating the lyophilized tissue material ofthe stent valve medical device contained around the intermediate portion of the inner member.
FIGS. 6 and 7 depict an alternative illustrative embodiment of Y-adaptor or connector 38 of delivery system 10 of FIG. 5. Here again, inner member 16 extends longitudinally through main arm lumen 64 as previously described with recessed or flat portion 35 in fluid communication with side arm lumen 63. Flexible polymeric material seal 62 now takes on the form of an O ring to facilitate a hemostatic seal between the inner member and the Y-adaptbr. At proximal end 65 of the Y-adaptor are apertures 66 and 67 extending transversely therethrough. A pair of transversely oriented, diametrically facing slots 68 are formed in inner member 16, which align with apertures 66 and 67 ofthe Y-adaptor. Two prong key 69 is inserted through the apertures and slots for fixedly positioning the inner member relative to the Y-adaptor. This fixedly positions the inner member with respect to the Y-adaptor not only longitudinally but also circumferentially. This advantageously maintains the position of recessed or flat portion 35 of the inner member with respect to the side arm lumen of the Y-ada'ptor. In addition, this is also utilized in combination with other structures which' will be described hereinafter to rotatioήally fix the position of the stent valve medical device contained at the distal end of the delivery catheter.
FIG.8 depicts an alternative illustrative embodiment of inner member 16 of delivery system 10 of FIG. 1, which can be used in combination with the Y- adaptor embodiment of FIGS.6 and 7. Positioned around intermediate portion 19 and, in particular, inner tube 25 is a cylindrical ring 70 of a flexible atraumatic material such as silicone and the like. This cylindrical ring of flexible material is positioned near the center of the intermediate portion ofthe inner member so as to engage wire frame segments or members of the stent valve medical device contained in the delivery system.
FIG.9 depicts a cross-sectional view of cylindrical ring 70 of intermediate portion 19 of FIG. 8 taken along the line 9-9 containing wire frame members 71 in delivery catheter 11. As depicted, cylindrical ring 70 is circumferentially positioned around inner tube 25 with delivery catheter 11 surrounding cylindrical ring 70 and wire frame members 71 of the contained medical device. As a result, the stent valve medical device of the present device is fixedly positioned circumferentially and longitudinally in the delivery system. Thus, the key at the proximal end ofthe Y-adaptor of FIG. 6 and 7 can be used to visually indicate the rotational orientation ofthe stent valve medical device contained in the delivery catheter at the distal end of the delivery system.
FIG. 10 depicts another illustrative embodiment of the positioning arrangement of delivery system 10 of FIG. 8. In this alternative' embodiment, the positioning member comprises a sleeve 72 having a cross-sectional shape with an elliptical circumference 73. As a result, the wire frame members or segments ofthe stent valve are positioned on either side ofthe major axis of the elliptically shaped sleeve. The orientation ofthe sleeve is aligned with that of the lock on the proximal end of the inner member to provide visual orientation of the stent valve contained at the distal end of the delivery system.
FIGS. 11 and 12 depict top and side views of still another illustrative embodiment of a positioning arrangement ofthe delivery system of FIG. 1 in which distal end 29 of outer tube 27 is shaped to engage one end of the stent valve medical device. In FIG. 11, the top and bottom of outer tube 27 have been skived or recessed so as to allow the wire frame segments to reside on either side of the tube. Recessed portions 74 and 75 engage the wire frame members of the device when contained in the delivery catheter. FIG. 12 depicts a top view of the outer tube with the sides ofthe tube beveled or tapered to form a duckbill configuration.
FIGS. 13 and 14 depict top and side views of another illustrative embodiment of distal tip portion 17 of the inner member of the delivery system of FIG. 1. In this embodiment, the proximal end 31 of the distal tip portion has been recessed on both sides as indicated by curvilinear surfaces 76 and 77. As depicted in FIG. 14, these curvilinear surfaces allow the other end as indicated by phantom lines 78 of the stent valve medical device to reside on the oppositely facing surfaces. As depicted in the top view of FIG. 13, the proximal end of curvilinear surface 76 has been rounded to minimize trauma or damage to surrounding tissue or the lyophilized tissue material of the stent valve.
FIGS. 15 and 16 depicttop and side views of still yet another embodiment of inner member 16 of the delivery system of FIG. 1. In the top view of FIG. 15, proximal end 31 of distal tip portion 17 includes oppositely facing curvilinear surfaces 76 and 77. Distal end 20 of outer tube 27 has oppositely facing recessed surfaces 74 and 75. Distal tip portion 17 and όutertϋbe !27 afe circumferentially positioned on inner tube 25 such that curvilinear 76 afid 77 are 90 degrees out of phase with respect to oppositely facing recessed 'surfaces' 74 arid 75. In this positioning arrangement, the 90 degrees out of phase ends as indicated by phantom lines 78 and 79 of the wire frame stent are engaged by and contained by the recessed surfaces.
FIG. 17 depicts a pictorial view of still yet another embodiment of inner member 16 of the delivery system of FIG. 1. To help;fluorόscopically visualize the orientation of distal end 20 of proximal portion 18/ two elongated segments of radiopaque material 80 and 81 are diametrically positioned in the distal end of outer tube 27. These radiopaque markers can be used with any of the embodiments previously discussed to further visualize the orientation of the stent valve medical device or the distal end of the proximal end portion of the ihner'member.
FIG. 18 depicts a pictorial view of yet still another embodiment of inner member 16 and, in particular, distal tip portion 17 of the delivery system of FIG. 1. In this embodiment, tapered proximal end 31 of distal tip portion 17 includes longitudinally offset recesses 45 and 46. Offset 45 has a diametrically opposed recess on the circumference of tapered proximal end 31, whereas offset recess 46 likewise has a corresponding diametrically opposed recess on the circumference ofthe tapered proximal end 31. These two pairs ofdiarrϊetrically opposed recesses are offset from one another to accept a pair of long struts of, for example, a venous valve in recess pair 46 and to accept a pair of shorter struts in longitudinal recess pair 45. These offset recesses capture the ends ofthe two different iength struts so as to maintain circumferential orientation of the medical device during placement. Furthermore, the medical device can be rotated with these longitudinally offset recesses for precise placement in the vasculature of a patient.
FIGS. 19 and 20 depict pictorial and side views of locking mechanism 47 of the delivery system of the present invention for fixedly positioning the relative position of delivery catheter 11 with respect to dilator or inner member 16. In this embodiment, a well-known and commercially available Check-Flo valve 48 with side arm 82 is connected to or made part of the proximal end of delivery catheter 11. This valve has an annular recess therearound as does the: distal end of inner member 16, which includes a well-known Luer-lock connector hub at its distal end. To fix the relative longitudinal position of the delivery catheter and inner member, locking mechanism 47 includes a pair of C-shaped clϊps';!which are interconnected by tie bar 47. The C-shaped clips of the locking mechanism are each clipped into a respective recess at the distal end of the delivery catheter and inner member so as to fix the relative position of each to one another. This locking mechanism can be readily removed by the attending physician when it is desired to withdraw the delivery catheter from the contained medical device. The locking mechanism advantageously prevents premature deployment of the medical device during the delivery and implantation procedure.
Enclosed herewith is an element list which isN provided as a convenience to relate the various elements of the delivery system as 'depicted in the drawings and described in the detailed description. This list of elements is provided for illustrative purposes only and is not to be construed to limit the present invention in any manner.
ELEMENT LIST
10 delivery system
11 delivery catheter
12 inner lumen of 11 proximal end of 11 distal end of 11 device-containing region of 11 inner member or dilator distal tip portion of 16 proximal portion of 16 intermediate portion of 16 blunt distal end of 18 irrigation lumen of 11 and 16 proximal end region of 35 tapered bonding area inner lumen of 16 inner tube of 16 radiolucent material of 25 coaxial outer tube of 16 radiopaque material of 27 distal end of 27 medical device tapered proximal end of 17 tapered distal end of 17 intermediate portion of 17 cylindrical outer surface of 18 recessed or flat portion of 18 radiopaque marker of 17 radiopaque material tube of 11 Y-connector main arm of 38 side arm of 38 hydration lumen lyophilized tissue material of 30 radiopaque markers of 30 wire frame stent of 30 offset recesses of 31 offset recesses of 31 locking mechanism Check-Flo valve C-shaped clips of 47 guide wire tie bar of 47 Luer-lock connector hub of 11 threaded lock tubing and valve proximal ends of tubes 25, 27 Luer-lock connector hub of 16 female part of 56 male part of 56 female part of 52 male part of 52 distal connector of 38 polymer material seal of 53 irrigation lumen of 40 main arm lumen of 38 proximal end of 39 apertures at 65 apertures at 65 slots on 16 two prong key cylindrical ring on 25 wire frame members sleeve on 25 elliptical circumference of 72 recessed portions at 29 recessed portions at 29 curvilinear surfaces of 31 curvilinear surfaces of 31 distal end of 30 79 proximal end of 30
80 radiopaque material
81 radiopaque material
82 side arm of 48
83 clear or transparent material tube of 11
It is to be understood that the above-described delivery systems are merely illustrative embodiments of the principles of this invention and that other medical device delivery systems may be devised by those skilled in the art without departing from the spirit and scope of this invention. In particular, the distal end of the proximal portion of the inner member may be configured to engage the proximal end of the medical device positioned in the intermediate portion of the inner member. Furthermore, the proximal end of the distal tip portion of the inner member can be configured in any number of different ways to receive and engage the distal end of the medical device. These configurations are used to engage and rotate the medical device while still being able to determine the orientation of the medical'devieVfrom the proximal end of the delivery system typically positioned outside of the patient during a purcutaneous vascular procedure.
Industrial Applicability
The present invention is useful for placement of a medical implantable device within a human or veterinary patient, and therefore finds applicability in human and veterinary medicine.
It is to be understood, however, that the above-described device is merely an illustrative embodiment of the principles of this invention, and that other devices and methods for using them may be' devised by those skilled in the art, without departing from the spirit and scope of the invention, It is also to be understood that the invention is directed to embodiments both comprising and consisting of the disclosed parts.

Claims

Claims
1. A medical device delivery system comprising: a delivery catheter having an inner lumen extending from a proximal end to a distal end and having a device-containing region adjacent the distal end; an inner member extendable through the delivery catheter from the proximal end to and through the device-containing region to and beyond the distal end of the delivery catheter, the inner member having a distal tip portion, a proximal portion, and an intermediate portion disposed between the distal tip portion and the proximal portion; and wherein the proximal portion has a distal end that is sized approximating the inner lumen of the delivery catheter at least through the device-containing region and that engages a medical device when the medical device is positioned around the intermediate portion and in' the device- containing region of the delivery catheter.
2. The delivery system of claim 1, wherein the intermediate portion is extendable through the device-containing region of the delivery catheter and wherein the proximal portion includes a proximal end region and an outer surface with a recessed portion communicating with the intermediate portion and extending to the proximal end region.
3. The delivery system of claim 1 , wherein the intermediate portion is sized and shaped to engage the medical device when the medical device is positioned around the intermediate portion.
4. The delivery system of claim 1, wherein the inner member includes an inner lumen extending longitudinally therethrough.
5. The delivery system of claim 1, wherein the inner member includes an inner tube extending longitudinally in the proximal, intermediate, and distal tip portions.
6. The delivery system of claim 5, wherein the inner tube comprises a radiolucent material.
7. The delivery system of claim 5, wherein the inner member includes an outer tube disposed around the inner tube in the proximal portion.
8. The delivery system of claim 7, wherein the outer tube comprises a radiopaque material.
9. The delivery system of claim 7, wherein the outer tube includes a blunt distal end communicating with the intermediate portion.
10. The delivery system of claim 1, wherein the distal tip portion includes a tapered proximal end communicating with the intermediate portion.
11. The delivery system of claim 10, wherein the distal tip portion also includes a radiopaque marker.
12. The delivery system of claim 11, wherein the distal- tip portion further includes an intermediate segment that is sized approximating the inner lumen of the delivery catheter about the distal end thereof.
13. The delivery system of claim 7, wherein the outer tube includes an outer surface that includes at least a recessed portion extending longitudinally therealong.
14. The delivery system of claim 13, wherein the delivery catheter includes a proximal portion having a lateral port that communicates with the recessed portion of the outer surface of the outer tube when the outer tube is positioned in the inner lumen of the delivery catheter.
15. The delivery system of claim 1, wherein the device-containing region of the delivery catheter includes a transparent material tube.
16. The delivery system of claim 1, further comprising an adapter connected to the proximal end of the delivery catheter and including a side arm communicating with a recessed portion of he inner member.
17. The delivery system of claim 1, further comprising an implantable medical device positionable around and engageable with the intermediate portion of the inner member and containable in the device-containing region of the delivery catheter, and wherein the medical device includes a lyophilized material that requires hydration prior to deployment.
18. A medical device delivery system comprising: a delivery catheter having an inner lumen extending from a proximal end to a distal end and having a device-containing region adjacent the distal end; , an inner member extending through the delivery catheter from the proximal end to and through the device-containing region to and beyond the distal end of the delivery catheter, and having a distal tip portion; and an implantable device contained in the device-containing region of the delivery catheter and around the inner member.
19. The delivery system of claim 18, wherein the inner member has an intermediate portion extending through the device-containing region and a proximal portion proximal of the intermediate portion' and wherein the proximal portion includes an outer surface with a recessed portion extending from the intermediate portion to a proximal end region of the inner member adjacent to a fluid injection port of the delivery catheter, the recessed portion being in communication with the device-containing region Of the delivery catheter.
20. The delivery system of claim 19, wherein the implantable device includes lyophilized material requiring hydration prior to deployment, whereby hydrating fluid is injectable into the fluid injection port and is transmitted along the recessed portion of the outer surface of the inner member within the delivery catheter to enter the device-containing region to hydrate the lyophilized material.
21. The delivery system of claim 19, wherein at least the intermediate portion of the inner member comprises a radiolucent material.
22. The delivery system of claim 18, wherein the inner member has an intermediate portion extending through the device-containing region and having a diameter less than a diameter of a proximal portion of the inner member and a diameter of the distal tip region of the inner member.
23. The delivery system of claim 22, wherein at least the intermediate portion of the inner member comprises a radiolucent material.
24. The delivery system of claim 23, wherein the implantable device includes at least one radiopaque marker that enables a clear contrast with the intermediate portion of the inner member.
25. The delivery system of claim 8, wherein the distal tip portion of the inner member includes a tapered proximal end extending to the intermediate portion.
26. The delivery system of claim 22, wherein the distal tip portion of the inner member includes an intermediate segment having a diameter about equal to a diameter of the inner lumen of the delivery catheter, and a tapered atraumatic distal end.
27. The delivery system of claim 22, wherein the proximal portion of the inner member adjacent to the intermediate portion and the device-containing region of the delivery catheter has a diameter approximating an inner diameter of the delivery catheter enabling the implantable device to abut the distal end of the proximal portion as the delivery catheter is being retracted during deployment of the implantable device at the deployment site, whereby no other member is needed to prevent proximal movement of the implantable device.
28. The delivery system of claim 18, wherein the inner member includes a guide wire lumen extending longitudinally therethrough, whereby enabling insertion of the delivery catheter containing the inner member over a guide wire in position in the patient.
29. The delivery system of claim 18, wherein the distal tip portion of the inner member includes a tapered distal end that is extendable beyond the distal end of the delivery catheter to engage a wall portion of the vessel spaced from the deployment site, thus tending to center the distal end of the delivery catheter within the vessel at the deployment site.
30. The delivery system of claim 29, wherein the implantable device includes at least one portion sufficiently engageable with the intermediate portion of the inner member, whereby the device tends to be initially centered within the vessel upon retraction of the distal end of the delivery catheter from therearound during deployment.
PCT/US2002/038289 2001-11-29 2002-11-27 Medical device delivery system WO2003045275A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA2466270A CA2466270C (en) 2001-11-29 2002-11-27 Medical device delivery system
DE60221289T DE60221289T2 (en) 2001-11-29 2002-11-27 FEEDING SYSTEM FOR MEDICAL DEVICES
EP02799890A EP1465546B1 (en) 2001-11-29 2002-11-27 Medical device delivery system
AU2002364514A AU2002364514B2 (en) 2001-11-29 2002-11-27 Medical device delivery system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33871401P 2001-11-29 2001-11-29
US60/338,714 2001-11-29

Publications (3)

Publication Number Publication Date
WO2003045275A2 WO2003045275A2 (en) 2003-06-05
WO2003045275A3 WO2003045275A3 (en) 2003-12-11
WO2003045275A9 true WO2003045275A9 (en) 2004-05-21

Family

ID=23325857

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038289 WO2003045275A2 (en) 2001-11-29 2002-11-27 Medical device delivery system

Country Status (6)

Country Link
US (1) US7871430B2 (en)
EP (1) EP1465546B1 (en)
AU (1) AU2002364514B2 (en)
CA (1) CA2466270C (en)
DE (1) DE60221289T2 (en)
WO (1) WO2003045275A2 (en)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838952T2 (en) 1997-11-07 2009-01-02 Salviac Ltd. EMBOLISM PROTECTION DEVICE
US7491216B2 (en) 1997-11-07 2009-02-17 Salviac Limited Filter element with retractable guidewire tip
US6918921B2 (en) 1999-05-07 2005-07-19 Salviac Limited Support frame for an embolic protection device
US6964672B2 (en) 1999-05-07 2005-11-15 Salviac Limited Support frame for an embolic protection device
GB2369575A (en) 2000-04-20 2002-06-05 Salviac Ltd An embolic protection system
US8038708B2 (en) 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
US20050228479A1 (en) * 2001-11-29 2005-10-13 Cook Incorporated Medical device delivery system
WO2003055412A2 (en) 2001-12-21 2003-07-10 Salviac Limited A support frame for an embolic protection device
US20040176759A1 (en) * 2003-03-07 2004-09-09 Subashini Krishnamurthy Radiopaque electrical needle
US20100185082A1 (en) * 2003-03-07 2010-07-22 Baylis Medical Company Inc. Device and method for electrosurgery
US7001369B2 (en) 2003-03-27 2006-02-21 Scimed Life Systems, Inc. Medical device
US7717952B2 (en) * 2003-04-24 2010-05-18 Cook Incorporated Artificial prostheses with preferred geometries
EP1615595B1 (en) * 2003-04-24 2009-10-21 Cook Incorporated Artificial valve prosthesis with improved flow dynamics
US7625399B2 (en) * 2003-04-24 2009-12-01 Cook Incorporated Intralumenally-implantable frames
US7658759B2 (en) * 2003-04-24 2010-02-09 Cook Incorporated Intralumenally implantable frames
GB0317359D0 (en) * 2003-07-24 2003-08-27 Angiomed Ag Adjustable safety clip
EP1691884B1 (en) * 2003-12-11 2011-03-23 Cook Incorporated Hemostatic valve assembly
US7641664B2 (en) * 2004-02-12 2010-01-05 Warsaw Orthopedic, Inc. Surgical instrumentation and method for treatment of a spinal structure
US8398663B2 (en) * 2004-02-27 2013-03-19 Cook Medical Technologies Llc Valvulotome device and method
US7717930B2 (en) * 2004-02-27 2010-05-18 Cook Incorporated Valvulotome with a cutting edge
US7449027B2 (en) * 2004-03-29 2008-11-11 Cook Incorporated Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes
US20050234499A1 (en) * 2004-04-19 2005-10-20 Scimed Life Systems, Inc. Multi-lumen balloon catheter including manifold
AU2005280151A1 (en) * 2004-08-26 2006-03-09 Cook Incorporated Delivery system with controlled frictional properties
CA2578706A1 (en) * 2004-09-01 2006-03-16 Cook Incorporated Delivery system which facilitates hydration of an intraluminal medical device
US7921874B2 (en) * 2004-11-12 2011-04-12 Cook Medical Technologies Llc Flow variation valve assembly
EP1877012B1 (en) * 2005-05-04 2017-04-26 Cook Medical Technologies LLC Expandable and retrievable stent
US8652193B2 (en) 2005-05-09 2014-02-18 Angiomed Gmbh & Co. Medizintechnik Kg Implant delivery device
US7901367B2 (en) * 2005-06-30 2011-03-08 Cook Incorporated Wire guide advancement system
EP1901796B1 (en) 2005-07-08 2020-11-11 C. R. Bard, Inc. Implantable medical device delivery apparatus
US8444602B2 (en) * 2005-09-09 2013-05-21 Cook Medical Technologies Llc Hemostatic valve system
US8162894B2 (en) * 2005-09-09 2012-04-24 Cook Medical Technologies Llc Valve opener
WO2008042270A1 (en) * 2006-09-28 2008-04-10 Med Institute, Inc. Endovascular delivery device
US8814847B2 (en) * 2007-07-13 2014-08-26 Cook Medical Technologies Llc Delivery system for percutaneous placement of a medical device and method of use thereof
US8518099B2 (en) * 2007-10-10 2013-08-27 C. R. Bard, Inc. Low friction vascular implant delivery device
US8858608B2 (en) * 2007-12-10 2014-10-14 Cook Medical Technologies Llc Lubrication apparatus for a delivery and deployment device
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US20090171279A1 (en) * 2007-12-26 2009-07-02 Cook Incorporated Balloon catheter assembly and controller therefor
US7566342B2 (en) * 2007-12-27 2009-07-28 Cook Incorporated Delivery system for medical device
US8114116B2 (en) * 2008-01-18 2012-02-14 Cook Medical Technologies Llc Introduction catheter set for a self-expandable implant
EP2293838B1 (en) 2008-07-01 2012-08-08 Endologix, Inc. Catheter system
US8308692B2 (en) * 2008-09-03 2012-11-13 Cook Incorporated Introducer for use in inserting a medical device into a body vessel and method for same
CA2752899A1 (en) * 2009-02-18 2010-08-26 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
GB2469506B (en) * 2009-04-16 2011-05-18 Cook William Europ Stent introducer apparatus
WO2011008537A1 (en) 2009-06-29 2011-01-20 Cook Incorporated Haemostatic valve device
US20120238806A1 (en) * 2009-08-24 2012-09-20 Quali-Med Gmbh Implantation system with handle and catheter and method of use thereof
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
ES2667059T3 (en) * 2010-08-17 2018-05-09 St. Jude Medical, Llc Tip for medical implant delivery system
US10112045B2 (en) 2010-12-29 2018-10-30 Medtronic, Inc. Implantable medical device fixation
US9775982B2 (en) 2010-12-29 2017-10-03 Medtronic, Inc. Implantable medical device fixation
WO2012118901A1 (en) 2011-03-01 2012-09-07 Endologix, Inc. Catheter system and methods of using same
GB201105622D0 (en) 2011-04-01 2011-05-18 Phangenesis Ltd Multi functional catheter
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
AU2012262549B2 (en) 2011-05-27 2016-02-11 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
WO2013071179A1 (en) 2011-11-10 2013-05-16 Transaortic Medical, Inc. System for deploying a device to a distal location across a diseased vessel
US9545298B2 (en) 2011-11-10 2017-01-17 Transaortic Medical, Inc. System for deploying a device to a distal location across a diseased vessel
US11213318B2 (en) 2011-11-10 2022-01-04 Medtronic Vascular, Inc. Expandable introducer sheath and method
EP2811923B1 (en) 2012-02-07 2019-10-16 Intervene, Inc. System for endoluminal valve creation
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
US9854982B2 (en) 2012-03-26 2018-01-02 Medtronic, Inc. Implantable medical device deployment within a vessel
US9220906B2 (en) 2012-03-26 2015-12-29 Medtronic, Inc. Tethered implantable medical device deployment
US9339197B2 (en) 2012-03-26 2016-05-17 Medtronic, Inc. Intravascular implantable medical device introduction
US9717421B2 (en) 2012-03-26 2017-08-01 Medtronic, Inc. Implantable medical device delivery catheter with tether
US9833625B2 (en) 2012-03-26 2017-12-05 Medtronic, Inc. Implantable medical device delivery with inner and outer sheaths
US10485435B2 (en) 2012-03-26 2019-11-26 Medtronic, Inc. Pass-through implantable medical device delivery catheter with removeable distal tip
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
CN105078615B (en) * 2012-09-21 2018-10-09 上海微创心通医疗科技有限公司 Interior tube assembly for implant delivery system
EP2908784B1 (en) * 2012-10-17 2017-07-12 Angiomed GmbH & Co. Medizintechnik KG Hand unit to release a self-expanding implant
US20140128964A1 (en) * 2012-11-08 2014-05-08 Symetis Sa Stent Seals and Methods for Sealing an Expandable Stent
WO2014110460A1 (en) 2013-01-10 2014-07-17 Intervene, Inc. Systems and methods for endoluminal valve creation
AU2014214700B2 (en) 2013-02-11 2018-01-18 Cook Medical Technologies Llc Expandable support frame and medical device
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
JP6753776B2 (en) 2013-05-17 2020-09-09 メドトロニック,インコーポレイテッド Expandable introducer sheath
JP6322374B2 (en) * 2013-08-12 2018-05-09 シルックス株式会社 Tube stent delivery device
US9782191B2 (en) 2014-01-21 2017-10-10 Cook Medical Technologies Llc Cutting devices and methods
US9849012B2 (en) * 2014-04-04 2017-12-26 W. L. Gore & Associates, Inc. Port retention mechanism for deployment handle of a medical device deployment system
US10195064B2 (en) 2014-08-15 2019-02-05 W. L. Gore & Associates, Inc. Endoprosthesis delivery systems with improved retraction
US9782561B2 (en) 2014-10-09 2017-10-10 Vacular Solutions, Inc. Catheter tip
US9636477B2 (en) 2014-10-09 2017-05-02 Vascular Solutions, Inc. Catheter
GB2532044A (en) 2014-11-06 2016-05-11 Phagenesis Ltd Catheter for recovery of dysphagia
JP2018524025A (en) 2015-06-30 2018-08-30 エンドロジックス、インク Lock assembly for coupling guidewire to delivery system
WO2017004377A1 (en) * 2015-07-02 2017-01-05 Boston Scientific Scimed, Inc. Adjustable nosecone
US10433952B2 (en) 2016-01-29 2019-10-08 Neovasc Tiara Inc. Prosthetic valve for avoiding obstruction of outflow
AU2017220022B2 (en) 2016-02-18 2021-06-10 Smiths Medical Asd, Inc. Closed system catheter
US11219746B2 (en) * 2016-03-21 2022-01-11 Edwards Lifesciences Corporation Multi-direction steerable handles for steering catheters
US10646247B2 (en) * 2016-04-01 2020-05-12 Intervene, Inc. Intraluminal tissue modifying systems and associated devices and methods
USD808013S1 (en) 2016-10-27 2018-01-16 Smiths Medical Asd, Inc. Catheter
AU2017361296B2 (en) 2016-11-21 2022-09-29 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
US10238834B2 (en) 2017-08-25 2019-03-26 Teleflex Innovations S.À.R.L. Catheter
US10856984B2 (en) 2017-08-25 2020-12-08 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
EP3510977A1 (en) * 2018-01-10 2019-07-17 Cook Medical Technologies LLC An endoluminal delivery device assembly
US10874850B2 (en) 2018-09-28 2020-12-29 Medtronic, Inc. Impedance-based verification for delivery of implantable medical devices
CA3118599A1 (en) 2018-11-08 2020-05-14 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US11602429B2 (en) 2019-04-01 2023-03-14 Neovasc Tiara Inc. Controllably deployable prosthetic valve
AU2020271896B2 (en) 2019-04-10 2022-10-13 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
US11331475B2 (en) 2019-05-07 2022-05-17 Medtronic, Inc. Tether assemblies for medical device delivery systems
EP3972673A4 (en) 2019-05-20 2023-06-07 Neovasc Tiara Inc. Introducer with hemostasis mechanism
WO2020257643A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve
US11812930B2 (en) * 2019-12-03 2023-11-14 Prodeon Medical Corporation Devices for the treatment of benign prostatic hyperplasia and related lower urinary tract symptoms

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US5693083A (en) * 1983-12-09 1997-12-02 Endovascular Technologies, Inc. Thoracic graft and delivery catheter
DK151404C (en) * 1984-05-23 1988-07-18 Cook Europ Aps William FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD
US4665918A (en) * 1986-01-06 1987-05-19 Garza Gilbert A Prosthesis system and method
US4830003A (en) 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5002560A (en) 1989-09-08 1991-03-26 Advanced Cardiovascular Systems, Inc. Expandable cage catheter with a rotatable guide
GB2238485B (en) * 1989-11-28 1993-07-14 Cook William Europ A collapsible filter for introduction in a blood vessel of a patient
CA2048307C (en) * 1990-08-14 1998-08-18 Rolf Gunther Method and apparatus for filtering blood in a blood vessel of a patient
US5830209A (en) * 1992-02-05 1998-11-03 Angeion Corporation Multi-fiber laser catheter
US5163953A (en) * 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5201757A (en) * 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5324304A (en) * 1992-06-18 1994-06-28 William Cook Europe A/S Introduction catheter set for a collapsible self-expandable implant
JPH08500757A (en) 1992-12-30 1996-01-30 シュナイダー・(ユーエスエイ)・インコーポレーテッド Device for deploying a stent implantable in the body
WO1994023786A1 (en) * 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system
US5683451A (en) 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5571168A (en) * 1995-04-05 1996-11-05 Scimed Lifesystems Inc Pull back stent delivery system
US5534007A (en) * 1995-05-18 1996-07-09 Scimed Life Systems, Inc. Stent deployment catheter with collapsible sheath
US5772669A (en) * 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US5843090A (en) * 1996-11-05 1998-12-01 Schneider (Usa) Inc. Stent delivery device
US6533807B2 (en) * 1998-02-05 2003-03-18 Medtronic, Inc. Radially-expandable stent and delivery system
JP4399585B2 (en) * 1998-06-02 2010-01-20 クック インコーポレイティド Multi-sided medical device
US6379365B1 (en) * 1999-03-29 2002-04-30 Alexis Diaz Stent delivery catheter system having grooved shaft
US6375676B1 (en) * 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
US6241758B1 (en) * 1999-05-28 2001-06-05 Advanced Cardiovascular Systems, Inc. Self-expanding stent delivery system and method of use
JP2003521334A (en) 2000-02-04 2003-07-15 ウィルソン−クック メディカル インコーポレイテッド Stent introducer device
US6945989B1 (en) * 2000-09-18 2005-09-20 Endotex Interventional Systems, Inc. Apparatus for delivering endoluminal prostheses and methods of making and using them
GB0023807D0 (en) * 2000-09-28 2000-11-08 Angiomed Ag Prosthesis carrying releasable substance
US6843802B1 (en) * 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent

Also Published As

Publication number Publication date
AU2002364514B2 (en) 2008-12-18
CA2466270A1 (en) 2003-06-05
WO2003045275A3 (en) 2003-12-11
US20030144670A1 (en) 2003-07-31
CA2466270C (en) 2010-09-14
AU2002364514A1 (en) 2003-06-10
WO2003045275A2 (en) 2003-06-05
EP1465546B1 (en) 2007-07-18
DE60221289D1 (en) 2007-08-30
DE60221289T2 (en) 2008-04-10
US7871430B2 (en) 2011-01-18
EP1465546A2 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
US7871430B2 (en) Medical device delivery system
US20050228479A1 (en) Medical device delivery system
US8814847B2 (en) Delivery system for percutaneous placement of a medical device and method of use thereof
US20240050703A1 (en) Augmented delivery catheter and method
US7608099B2 (en) Medical appliance delivery apparatus and method of use
EP0350043B1 (en) Mechanically locking blood clot filter
US6709415B2 (en) Intraluminal catheter with expandable tubular open-walled element
US6852116B2 (en) Method for engrafting a blood vessel
US9126016B2 (en) Augmented delivery catheter and method
US8506623B2 (en) Implant delivery and deployment system and method
US7527643B2 (en) Exchangeable delivery system for expandable prosthetic devices
EP0809476B1 (en) Endoprosthesis stent/graft deployment system
JPH0759802A (en) Multicapsule intraluminal implant device
JPH0838486A (en) System and method for forked form multicapsule pipe intracavitary transplant
WO2007035895A2 (en) Endoluminal stent graft delivery assembly
WO2009146128A1 (en) Implant release mechanism
WO2011008538A1 (en) Slotted pusher rod for flexible delivery system
US20140121751A1 (en) Cannula attachment in endoluminal delivery devices
GB2503000A (en) Implantable vascular occluder or filter
WO2018144971A1 (en) Implantable medical device system and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2466270

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002799890

Country of ref document: EP

COP Corrected version of pamphlet

Free format text: PAGES 1-20, DESCRIPTION, REPLACED BY NEW PAGES 1-20; PAGES 21-24, CLAIMS, REPLACED BY NEW PAGES 21-24; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 2002364514

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2002799890

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2002799890

Country of ref document: EP